summari ew report underli revenu
underli in-lin estim
ahead street adj ep
report in-lin consensu estim
ew underli global thv transcathet heart valv
sale underli fell short
consensu expect ew thv
growth reflect mid-teen tavr transcathet aortic valv
replac growth us market growth ou
expect contribut
transcathet mitral/tricuspid
therapi tmtt minim regard
outlook ew re-affirmed guidanc previous laid
decemb investor day includ total sale
underli growth includ tavr growth
underli bottom-lin ew maintain ep
guidanc report addit ew
guid sale estim impli
underli growth midpoint compar
consensu estim respect
ew ep guidanc report
street expect previou estim
guidanc came expect
entir surpris us given ew signal investor
day growth expect ramp throughout year driven
new product introduct tavr mitral
pipelin front materi updat
vantag point time variou product consist
ew investor day
all-in-al rel unev call view given
ew re-affirmed outlook commentari upcom
low-risk data limit time ew
pipelin product unchang
lower sale estim
underli maintain adj ep estim
report rais price target
assum adj ep estim
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
thv short street estim underli ww thv sale came
street expect estim tavr front ew
estim ww procedur grew mid-teen compani growth lower due ou
dynam regard us manag said ew growth compar mid-teen market
procedur growth ou outsid us ew said tavr procedur grew mid-teen ew
procedur grew low double-digit europ specif ew estim market procedur growth
mid-teen led countri tavr less establish get insight
 ou market dynam report earn februari ew continu expect
ww tavr sale underli growth
data schedul march ew host event result ew sapien
low-risk studi schedul present sunday march american colleg
cardiolog ew reserv commentari topic note updat withdraw
supplement prior statement relat topic recal ew said previous
expect favor result fda approv expect late assum
guidanc ew plan host analyst meet march also webcast
control launch ultra centera go ew said control rollout ultra
us eu centera eu go well manag note plan replac case
ultra time would expect bulk convers europ occur year-end separ
ew said enrol centera pivot trial intermedi risk patient expect complet
suppli constraint continu impact cardioband pascal eu launch track expect
contribut transcathet mitral/tricuspid therapi tmtt minim due
on-going suppli constraint manag expect see progress improv cardioband
suppli front work transit product israel regard pascal manag
said ce mark time eu launch expect mid-year chang previou time ew
note pascal ce mark data like present upcom dgk german societi
cardiolog europcr meet april may respect ew said clasp iid
degen mitral regurgit pivot trial continu enrol activ new site
clasp iif function mitral regurgit pivot trial still expect initi late ew
continu expect sale contribut tmtt product
sale underli ahead consensu estim
result driven solid aortic unit volum growth continu adopt ew latest premium
surgic heart valv inspiri manag note inspiri see particularli good adopt younger
patient ew continu expect ssh sale underli growth
cc sale underli beat consensu estim
result driven strong perform across categori led hemospher growth ew
esr enhanc surgic recoveri platform manag note cc busi
particularli strong theme consist previou quarter ew continu expect cc sale
underli growth
top-lin outlook re-affirmed call ew re-affirmed guidanc laid
decemb investor day includ total sale underli growth
tavr growth underli regard currenc impact sale fx expect
headwind vs hit prior move ew reiter guidanc
follow item gross margin sg spend sale spend
sale tax rate excl special item bottom-lin ew maintain ep
guidanc report
ep guidanc street ew guid sale estim
impli underli growth midpoint compar consensu estim
respect ew ep guidanc report
street expect previou estim guidanc came
expect entir surpris us given ew signal investor day
growth expect ramp throughout year driven new product introduct tavr
price target
price target assum ep estim risk includ greater
share loss model delay mitral program neg clinic data
believ upcom data pipelin product help ew address new competit
transcathet mitral valv opportun signific catalyst
irvin california -base edward lifesci ew develop manufactur market product
design heart valv diseas cardiac surgeri critic care edward revenu reach
billion come transcathet heart valv therapi thv busi ew
player transcathet heart valv therapi market
edward lifesci incom statementin million except per share good sold excl gross oper oper expens expens incom pre-tax debt net adj dilut analysi gross bp bp bp oper bp growthnet incom dilut oper share qtr/qtr except dilut compani report secur llc estim medic technolog
